2021 Essex County Council election

Peptilogics to Present First-in-Human Phase 1 Clinical Data of PLG0206 at IDWeek 2021

Wednesday, September 22, 2021 - 1:00pm

PLG0206 has a unique mechanism of action that works by targeting and disrupting bacterial membranes leading to the rapid killing of bacterial cells.

Key Points: 
  • PLG0206 has a unique mechanism of action that works by targeting and disrupting bacterial membranes leading to the rapid killing of bacterial cells.
  • Using unique peptide engineering techniques, Peptilogics has optimized PLG0206 both for safety and broad-spectrum activity against biofilms produced by bacteria that harbor and protect bacteria from most antibiotics.
  • Peptilogics will present data from three accepted abstracts including its first-in-human Phase 1 clinical safety data, results from a PJI patient explant study, and in vitro activity against bacteria commonly found in PJIs.
  • Peptilogics is backed by visionary investors in life science and technology including Thiel Capital, Presight Capital, CARB-X, and Founders Fund.

New Study by Curelator Reveals Surprisingly Variable Relationship between Peak Pain Severity and Stress in Individuals with Chronic Migraine

Wednesday, September 22, 2021 - 11:59am

CAMBRIDGE, Mass., Sept. 22, 2021 /PRNewswire/ -- Curelator Inc. today announced new data with what is the first study to prospectively examine daily peak pain severity patterns and the day-to-day relationship between peak severity and perceived stress, in individuals with chronic migraine.

Key Points: 
  • - The study concluded that, on average, peak pain severity was higher on days in which the individual perceived higher stress levels.
  • CAMBRIDGE, Mass., Sept. 22, 2021 /PRNewswire/ -- Curelator Inc. today announced new data with what is the first study to prospectively examine daily peak pain severity patterns and the day-to-day relationship between peak severity and perceived stress, in individuals with chronic migraine.
  • Some individuals showed no relationship between stress and peak pain severity, or even presented lower peak severity on days with higher stress.
  • Perceived stress and pain severity in individuals with chronic migraine: a longitudinal cohort study using daily prospective diary data.

New Study by Curelator Reveals Surprisingly Variable Relationship between Peak Pain Severity and Stress in Individuals with Chronic Migraine

Wednesday, September 22, 2021 - 11:58am

CAMBRIDGE, Mass., Sept. 22, 2021 /PRNewswire/ -- Curelator Inc. today announced new data with what is the first study to prospectively examine daily peak pain severity patterns and the day-to-day relationship between peak severity and perceived stress, in individuals with chronic migraine.

Key Points: 
  • CAMBRIDGE, Mass., Sept. 22, 2021 /PRNewswire/ -- Curelator Inc. today announced new data with what is the first study to prospectively examine daily peak pain severity patterns and the day-to-day relationship between peak severity and perceived stress, in individuals with chronic migraine.
  • divorce or death of a family member, may increase the risk of progression to chronic migraine, whilst day to day stress levels may be associated with occurrence and/or the peak pain severity of migraine attacks.
  • Some individuals showed no relationship between stress and peak pain severity, or even presented lower peak severity on days with higher stress.
  • Perceived stress and pain severity in individuals with chronic migraine: a longitudinal cohort study using daily prospective diary data.

CorEvitas and Inovalon Leverage Advanced Analytics to Deliver A Holistic View of the Patient

Tuesday, September 21, 2021 - 3:00pm

"We are excited to collaborate with CorEvitas to accelerate these insights with an initial focus on rheumatoid arthritis and psoriasis."

Key Points: 
  • "We are excited to collaborate with CorEvitas to accelerate these insights with an initial focus on rheumatoid arthritis and psoriasis."
  • Insights made possible through these analytics can advance clinical development, inform trial design and recruitment, substantiate value narratives, and inform patient-specific intervention plans.
  • Raymond Hill, Chairman and Chief Executive Officer for CorEvitas, noted, "As an organization, we recognize the immeasurable value of understanding the whole patient.
  • By furthering our collaboration with Inovalon, we can leverage the data-driven insights that provide integrated and actionable insights for the patient.

Gilead to Present Latest Antiviral Research Data Addressing Urgent Global Needs in Infectious Disease at IDWeek 2021

Monday, September 20, 2021 - 1:30pm

As announced in August 2021, the MAA has been fully validated and is now under evaluation with the EMA.

Key Points: 
  • As announced in August 2021, the MAA has been fully validated and is now under evaluation with the EMA.
  • Veklury is contraindicated in patients with a history of clinically significant hypersensitivity reactions to Veklury or any of its components.
  • Veklury, Biktarvy, Descovy, Descovy for PrEP, Gilead and the Gilead logo are registered trademarks of Gilead Sciences, Inc., or its related companies.
  • For more information about Gilead, please visit the companys website at www.gilead.com , follow Gilead on Twitter ( @Gilead Sciences ) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.

Research Conducted by Florida Cancer Specialists & Research Institute Presented at European Society of Medical Oncology 2021 Congress

Friday, September 17, 2021 - 5:33pm

FCS President and Managing Physician Lucio Gordan, MD said, Our FCS Clinical Research Program continues to set a national benchmark for community oncology.

Key Points: 
  • FCS President and Managing Physician Lucio Gordan, MD said, Our FCS Clinical Research Program continues to set a national benchmark for community oncology.
  • The ESMO Congress 2021 is a global stage for the exchange of potentially practice-changing data and multidisciplinaryconversations that will spur transformative therapies against cancer.
  • Recognized by the American Society of Clinical Oncology (ASCO) with a national Clinical Trials Participation Award, Florida Cancer Specialists & Research Institute (FCS) offers patients access to more clinical trials than any private oncology practice in Florida.
  • Over the past 5 years, the majority of new cancer drugs approved for use in the U.S. were studied in clinical trials with Florida Cancer Specialists participation.

Biodesix Announces Abstracts Presented During the IASLC 2021 World Conference on Lung Cancer

Thursday, September 16, 2021 - 2:20pm

Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced that two abstracts highlighting proteomic and genomic data based on their diagnostic tests were presented at the International Association for the Study of Lung Cancer (IASLC) World Conference on Lung Cancer (WCLC).

Key Points: 
  • Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced that two abstracts highlighting proteomic and genomic data based on their diagnostic tests were presented at the International Association for the Study of Lung Cancer (IASLC) World Conference on Lung Cancer (WCLC).
  • The authors point out that while immunotherapy is very effective treating many patients with lung cancer, not all patients with lung cancer benefit.
  • These abstracts highlight the effectiveness of our approach in utilizing multiple technologies to determine the best treatment plans as rapidly as possible for patients with lung cancer.
  • The blood based Biodesix Lung Reflex strategy for lung cancer patients integrates the GeneStrat and VeriStrat tests to support treatment decisions with results in 36 hours, expediting time to treatment.

Untangle Simplifies SD-WAN Setup with Command Center Release

Thursday, September 16, 2021 - 2:00pm

Managed Service Providers (MSPs) and their customers can now deploy and automatically connect network appliances like Untangle NG Firewalls and SD-WAN Routers directly from Command Center, from any location.

Key Points: 
  • Managed Service Providers (MSPs) and their customers can now deploy and automatically connect network appliances like Untangle NG Firewalls and SD-WAN Routers directly from Command Center, from any location.
  • Command Center streamlines the setup and management of networks that have multiple appliances saving administrators time and reduces the complexity of connecting remote offices by automatically creating secure connections between appliances in a network.
  • Untangle Command Center simply needs to know what to connect, and it abstracts all the hard work so that administrators can relax as their network is provisioned for them."
  • Command Center is free to use for customers with Untangle NG Firewall Complete subscriptions and/or Untangle SD-WAN Routers with paid subscriptions.

Y-mAbs Announces Data to be Presented at SIOP 2021

Thursday, September 16, 2021 - 2:00pm

As a result of this licensing arrangement, MSK has institutional financial interests in the compounds.

Key Points: 
  • As a result of this licensing arrangement, MSK has institutional financial interests in the compounds.
  • This indication was approved under accelerated approval based on overall response rate and duration of response.
  • Continued approval for this indication may be contingent upon verification and description of clinical benefits in a confirmatory trial.
  • Y-mAbs is a commercial-stage biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer.

Genetron Health Unveils 13 Cancer Research findings at ESMO Congress 2021

Thursday, September 16, 2021 - 11:00am

The research adopted Genetrons proprietary technology such as the One-Step Seq Method, and core products such as Onco PanScanand its thyroid cancer full-cycle gene test.

Key Points: 
  • The research adopted Genetrons proprietary technology such as the One-Step Seq Method, and core products such as Onco PanScanand its thyroid cancer full-cycle gene test.
  • These findings were from both multi-cancer studies and high-risk single cancer studies, which covered lung cancer, thyroid cancer, cholangiocarcinoma, and central nervous system cancers.
  • Genetron Health's research findings provide new strategies for precise diagnosis and treatment of the Chinese population.
  • For these patients, Genetron Health has developed a full-cycle gene test for thyroid cancer that is based on the One-Step Seq Method.